Search
Silence Therapeutics PLC
SLNAdd to Watchlist
19.750USD
-0.050-0.25%
Close 10-30 16:00（ET）
1.23BMarket Cap
LossP/E TTM
Silence Therapeutics PLC (SLN) Stock Price Target & Forecast
Analyst Rating
Based on 7 analysts giving stock ratings to Silence Therapeutics PLC in the past month.
Hold
2 Strong Buy
4 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
23.000USD+16.69%
SLN Analyst Recommendation Trends
In the current month, SLN has received 4 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. SLN average Analyst price target in the last month is 23.000.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
2
2
2
2
4
4
4
4
3
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
7
7
7
7
6
6
6
6
SLN Analyst Rating for Peer Comparison
Updated: Nov 1, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
11
8
0
0
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.25
-0.32
-0.26
Surprise
--
--
--
FAQs
What is Silence Therapeutics PLC's price target?
Analysts forecast that Silence Therapeutics PLC's price target is USD 23.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 20.00.
What is the analyst rating for Silence Therapeutics PLC?
Based on the ratings of Silence Therapeutics PLC's stock from 7 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.